The Pharmaceutical Journal
Vol 279 No 7461 p66
21 July 2007

This article
Reprint   Photocopy

  Acrobat Reader

News summary

Anticoagulants and antiplatelets

Adding an oral anticoagulant to antiplatelet therapy does not reduce the likelihood of patients with peripheral arterial disease experiencing a major cardiovascular complication and increases the chance of a life-threatening bleed occurring, data from a study published in The New England Journal of Medicine show (2007;357:217).